Your browser doesn't support javascript.
Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy.
Loconsole, Daniela; Centrone, Francesca; Morcavallo, Caterina; Campanella, Silvia; Accogli, Marisa; Sallustio, Anna; Peccarisi, Davide; Stufano, Angela; Lovreglio, Piero; Chironna, Maria.
  • Loconsole D; Department of Biomedical Sciences and Human Oncology-Hygiene Section, School of Medicine, University of Bari, 70124 Bari, Italy.
  • Centrone F; Department of Biomedical Sciences and Human Oncology-Hygiene Section, School of Medicine, University of Bari, 70124 Bari, Italy.
  • Morcavallo C; Department of Biomedical Sciences and Human Oncology-Hygiene Section, School of Medicine, University of Bari, 70124 Bari, Italy.
  • Campanella S; Department of Biomedical Sciences and Human Oncology-Hygiene Section, School of Medicine, University of Bari, 70124 Bari, Italy.
  • Accogli M; Department of Biomedical Sciences and Human Oncology-Hygiene Section, School of Medicine, University of Bari, 70124 Bari, Italy.
  • Sallustio A; Hygiene Unit, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, 70124 Bari, Italy.
  • Peccarisi D; Department of Biomedical Sciences and Human Oncology-Hygiene Section, School of Medicine, University of Bari, 70124 Bari, Italy.
  • Stufano A; Interdisciplinary Department of Medicine-Section of Occupational Medicine, School of Medicine, University of Bari, 70124 Bari, Italy.
  • Lovreglio P; Interdisciplinary Department of Medicine-Section of Occupational Medicine, School of Medicine, University of Bari, 70124 Bari, Italy.
  • Chironna M; Department of Biomedical Sciences and Human Oncology-Hygiene Section, School of Medicine, University of Bari, 70124 Bari, Italy.
Vaccines (Basel) ; 9(11)2021 Nov 18.
Article in English | MEDLINE | ID: covidwho-1524228
ABSTRACT
Differences in the demographic and clinical characteristics of patients infected with the Alpha and Delta SARS-CoV-2 variants of concern in a large region of Southern Italy were assessed. Two cohorts of positive patients were compared. The Alpha group consisted of 11,135 subjects diagnosed between 21 March and 21 April 2021, and the Delta group consisted of 499 positive subjects diagnosed between 21 July and 21 August 2021. A descriptive and statistical analysis of the demographic and clinical characteristics of the two groups was performed. The proportion of patients with mild and moderate infections was significantly higher in the Delta than in the Alpha group (p < 0.001). In fully vaccinated patients, the proportion of symptomatic individuals was significantly higher in the Delta than in the Alpha group. The Delta group showed odds ratios of 3.08 (95% CI, 2.55-3.72) for symptomatic infection and 2.66 (95% CI, 1.76-3.94) for hospitalization. Improving COVID-19 vaccination rates is a priority, since infection with the SARS-CoV-2 Delta variant has a significant impact on patient outcomes. Additional targeted prevention strategies such as social distancing, the use of masks in indoor settings irrespective of vaccination status, and the use of a sanitary passport could be crucial to contain further spread of SARS-CoV-2 infection.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9111354

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9111354